Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
TANDEM DIABETES CARE INC | Director | Common Stock | 205K | $10.6M | $51.73 | May 23, 2024 | Indirect |
TANDEM DIABETES CARE INC | Director | Common Stock | 17.8K | $923K | $51.73 | May 24, 2024 | Direct |
Nuvation Bio Inc. | Director | Class A Common Stock | 172K | $500K | $2.90 | Jun 11, 2024 | By Trust |
TANDEM DIABETES CARE INC | Director | Restricted Stock Unit | 4.39K | $227K | $51.73 | May 23, 2024 | Direct |
Nuvation Bio Inc. | Director | Stock Option (Right to Buy) | 201K | Sep 3, 2024 | Direct | ||
TANDEM DIABETES CARE INC | Director | RSU 2023 05 24 | 4.43K | May 24, 2023 | Direct | ||
Opy Acquisition Corp. I | Director | Common Stock | 0 | Oct 26, 2021 | Direct |